Blue Jet Healthcare's Latest Updates

Offer for Sale (OFS) by Promoter: The company's promoter, Akshay Bansarilal Arora, announced an Offer for Sale (OFS) of shares in September 2025, which included an over-subscription option. The floor price for the sale was set at a discount to the market price at that time, and the sale was conducted to meet minimum public shareholding requirements. Manufacturing Expansion: Blue Jet Healthcare is set to develop a new greenfield Contract Development and Manufacturing Organization (CDMO) facility in Andhra Pradesh on a 102.48-acre land parcel. The first phase of this project is expected to involve an investment of over ₹1,000 crore to build an initial manufacturing capacity of up to 1,000 kilolitres (KL), aiming to be operational by FY 2028-29. Q1 FY26 Financial Performance: For the April-June quarter of the fiscal year 2025-26, the company reported a significant rise in its Profit After Tax (PAT) of ₹91.2 crore, up 141.3% year-over-year. Revenue from operations also saw strong growth, increasing by 117.8% to ₹354.8 crore in the same period. Dividend Announcement: The company announced a dividend of ₹1.20 per share, which represented an increase from the comparable payment of the previous year. The ex-dividend date was September 19, 2025, with the payment scheduled for October 26, 2025. Corporate Recognition and Meetings: In September 2025, Blue Jet Healthcare received the 'Excellent Energy Efficient Unit' award at the 26th National Award for Excellence in Energy Management. The company also announced the outcome of its Annual General Meeting (AGM) and communicated the closure of its trading window around the same time.